Squamous cell carcinoma (SCC) of the lung has a markedly different molecular profile to
adenocarcinoma of the lung and remains difficult to treat because of the lack of targeted …

Squamous cell carcinoma (SCC) represents the second most common histologic subtype of
lung cancer (preceded only by adenocarcinoma). SSC of the lung is prevalently diagnosed …

Squamous cell lung cancer (SqCLC) is a distinct histologic subtype of NSCLC that is
challenging to treat because of specific clinicopathologic characteristics, which include older …

Squamous cell lung cancer (SCC) represents an area of unmet need in lung cancer
research. For the past several years, therapeutic progress in SCC has lagged behind the …

Squamous cell lung cancer (sqCLC) is an aggressive form of cancer that poses many
therapeutic challenges. Patients tend to be older, present at a later stage, and have a high …

Squamous cell carcinoma (SQCC) of the lung is the second-largest subtype of non-small
cell lung cancer (NSCLC), causing an estimated 400,000 deaths per year worldwide …

Options for the treatment of squamous cell lung carcinoma expanded in recent years with
the introduction of the immune checkpoint inhibitors into routine clinical practice in both the …

Until recently, few treatment options existed for the treatment of squamous cell carcinoma
(SqCC) of the lung, especially in the second-line setting following platinum-based …

Abstract Treatment for non–small cell lung cancer has been improving, with personalized
treatment increasingly becoming a reality in the clinic. Unfortunately, these advances have …

New developments in the treatment of squamous cell lung canc... : Current Opinion in
Oncology New developments in the treatment of squamous cell lung cancer : Current …